BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

Earnings

Average move on report day±10.7%last 13 reports
Closed higher5 of 1338% of the time
Best reaction+41.0%
Worst reaction-15.0%

Stock move on the day after each report

+41.0%2023/Q4-2.6%2024/Q1-5.9%2024/Q2-3.1%2024/Q3+12.4%2024/Q4-14.1%2025/Q1-14.0%2025/Q2+0.2%2025/Q3+4.1%2025/Q4+7.9%2026/Q1-8.4%2026/Q2-11.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q32 Nov 2026Pre Market±8.9%-10.95%Bigger than priced
2026/Q23 Aug 2026Pre Market±10.7%-8.37%Within range
2026/Q14 May 2026Pre Market±8.3%+7.86%Within range
2025/Q417 Feb 2026Pre Market±8.1%+4.12%Within range
2025/Q33 Nov 2025Pre Market±11.4%+0.17%Within range
2025/Q24 Aug 2025Pre Market±11.5%-14.04%Bigger than priced
2025/Q16 May 2025Pre Market±11.0%-14.06%Bigger than priced
2024/Q419 Feb 2025Pre Market±13.3%+12.43%Within range
2024/Q34 Nov 2024Pre Market±13.9%-3.14%Within range
2024/Q25 Aug 2024Pre Market±15.0%-5.85%Within range
2024/Q16 May 2024Pre Market±13.0%-2.58%Within range
2023/Q426 Feb 2024Pre Market±17.0%+41.02%Bigger than priced
2023/Q36 Nov 2023Pre Market±13.9%-15.05%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$127.34M+30.2% YoY
Operating profit$71.15M+72.0% YoY
Net profit$63.07M-20.5% YoY
Diluted EPS$2.05-22.9% YoY
Free cash flow$90.25M+137.8% YoY
Operating cash flow$91.25M

Revenue, last 8 quarters

$91.1MDec '24$88.2MMar '25$96.0MJun '25$97.8MSep '25$107.1MDec '25$116.4MMar '26$119.2MJun '26$127.3MSep '26

Net profit, last 8 quarters

$45.5MDec '24$35.7MMar '25$38.3MJun '25$79.4MSep '25$51.4MDec '25$55.9MMar '26$54.8MJun '26$63.1MSep '26

Profitability & balance sheet

Gross margin94.3%
Operating margin48.4%
Net margin47.9%
Return on equity17.5%
Return on assets15.9%
Return on invested capital15.3%
Current ratio7.89
Liabilities / assets9.5%
Cash & investments$911.85M
Total debt$6.77M
Net cash (debt)$905.08M
Free cash flow / sales66.0%

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top